8-CI Camp as Anti-Cancer Drug
US Patent 5,902,794
Filed on 1997-09-22
Filed on 1997-09-22
O2-ARYLATED OR O2-GLYCOSYLATED 1-SUBSTITUTED DIAZEN-1-IUM-1,2-DIOLATES AND O2-SUBSTITUTED 1-[(2-CARBOXYLATO)PYRROLIDIN-1-YL]DIAZEN-1-IUM ...
Patent Cooperation Treaty
PCT/US1997/017267
Filed on 1997-09-26
PCT/US1997/017267
Filed on 1997-09-26
METHODS OF IDENTIFYING PATIENTS HAVING AN ALTERED IMMUNE STATUS
US Patent 5,658,744
Filed on 1994-07-22
Filed on 1994-07-22
EVALUATION AND TREATMENT OF PATIENTS WITH PROGRESSIVE IMMUNOSUPPRESSION
US Patent 5,889,143
Filed on 1996-09-16
Filed on 1996-09-16
SHORT-TERM ANTI-CD3 STIMULATION OF LYMPHOCYTES TO INCREASE THEIR IN VIVO ACTIVITY
US Application 08/251,860
Filed on 1994-05-31
Filed on 1994-05-31
EVALUATION AND TREATMENT OF PATIENTS WITH PROGRESSIVE IMMUNOSUPPRESSION
US Patent 5,556,763
Filed on 1993-03-17
Filed on 1993-03-17
THE ERF GENETIC LOCUS AND ITS PRODUCTS
US Patent 6,194,547
Filed on 1998-02-10
Filed on 1998-02-10
Protease-Activatable Pseudomonas Exotoxin A-Like Proproteins
Patent Cooperation Treaty
PCT/US1997/020207
Filed on 1997-11-05
PCT/US1997/020207
Filed on 1997-11-05